Markus Bieringer

1.3k total citations
17 papers, 607 citations indexed

About

Markus Bieringer is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Surgery. According to data from OpenAlex, Markus Bieringer has authored 17 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Genetics and 4 papers in Surgery. Recurrent topics in Markus Bieringer's work include Vasculitis and related conditions (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Platelet Disorders and Treatments (2 papers). Markus Bieringer is often cited by papers focused on Vasculitis and related conditions (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Platelet Disorders and Treatments (2 papers). Markus Bieringer collaborates with scholars based in Germany, United Kingdom and Switzerland. Markus Bieringer's co-authors include Friedrich C. Luft, Dominik N. Müller, Anette Fiebeler, Joon-Keun Park, Ralf Dechend, Hermann Haller, Eero Mervaala, Volker Breu, Folke Schmidt and Detlev Ganten and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Kidney International.

In The Last Decade

Markus Bieringer

16 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Bieringer Germany 8 256 212 209 183 75 17 607
Eileen Blasi United States 10 215 0.8× 190 0.9× 377 1.8× 287 1.6× 68 0.9× 14 715
Mathias Burgmaier Germany 20 420 1.6× 354 1.7× 283 1.4× 265 1.4× 40 0.5× 55 1.0k
Joerg Kreuzer Germany 11 124 0.5× 320 1.5× 193 0.9× 123 0.7× 38 0.5× 21 732
Ikuko Nakamura Japan 10 106 0.4× 222 1.0× 241 1.2× 210 1.1× 141 1.9× 19 699
Yasunori Iwashima Japan 16 298 1.2× 158 0.7× 315 1.5× 216 1.2× 75 1.0× 36 780
Masafumi Myoishi Japan 12 188 0.7× 284 1.3× 210 1.0× 278 1.5× 32 0.4× 16 928
Michelle McNabb United States 6 156 0.6× 120 0.6× 242 1.2× 314 1.7× 118 1.6× 6 1.3k
Lijun Ma China 6 96 0.4× 137 0.6× 164 0.8× 155 0.8× 41 0.5× 7 487
Chun Xi Liu China 13 122 0.5× 381 1.8× 155 0.7× 179 1.0× 25 0.3× 15 654
Sheng Jiao China 15 245 1.0× 99 0.5× 180 0.9× 224 1.2× 71 0.9× 37 685

Countries citing papers authored by Markus Bieringer

Since Specialization
Citations

This map shows the geographic impact of Markus Bieringer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Bieringer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Bieringer more than expected).

Fields of papers citing papers by Markus Bieringer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Bieringer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Bieringer. The network helps show where Markus Bieringer may publish in the future.

Co-authorship network of co-authors of Markus Bieringer

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Bieringer. A scholar is included among the top collaborators of Markus Bieringer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Bieringer. Markus Bieringer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Jabs, Wolfram J., Volker Vielhauer, Markus Bieringer, et al.. (2024). Avacopan in Anti-Neutrophil Cytoplasmic Autoantibodies–Associated Vasculitis in a Real-World Setting. Kidney International Reports. 9(9). 2803–2808. 13 indexed citations
2.
Klocke, Jan, Diana Metzke, Udo Schneider, et al.. (2024). Urinary CD4+ T Cells Predict Renal Relapse in ANCA-Associated Vasculitis. Journal of the American Society of Nephrology. 35(4). 483–494. 7 indexed citations
3.
Klocke, Jan, Markus Bieringer, Anthony Rousselle, et al.. (2023). Urinary T Cells Identify Renal Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Predict Prognosis: A Proof of Concept Study. Kidney International Reports. 8(4). 871–883. 6 indexed citations
4.
Ebert, M., Uwe Jerke, Dieter E. Jenne, et al.. (2022). Protective α1-antitrypsin effects in autoimmune vasculitis are compromised by methionine oxidation. Journal of Clinical Investigation. 132(23). 12 indexed citations
5.
Rousselle, Anthony, Kerstin Amann, Alexander Mildner, et al.. (2022). CSF2-dependent monocyte education in the pathogenesis of ANCA-induced glomerulonephritis. Annals of the Rheumatic Diseases. 81(8). 1162–1172. 20 indexed citations
6.
Kühne, Lucas, Jessica Kaufeld, Linus A. Völker, et al.. (2022). Alternate‐day dosing of caplacizumab for immune‐mediated thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 20(4). 951–960. 17 indexed citations
7.
Klocke, Jan, Markus Bieringer, Saban Elitok, et al.. (2020). THU0321 URINARY T CELLS IDENTIFY ACTIVE RENAL ANCA ASSOCIATED VASCULITIS. Annals of the Rheumatic Diseases. 79. 390–390. 1 indexed citations
8.
Elitok, Saban, et al.. (2019). A patient with chronic kidney disease, primary biliary cirrhosis and metabolic acidosis. Clinical Kidney Journal. 13(3). 463–467. 4 indexed citations
9.
Arends, Christopher Maximilian, Anthony Rousselle, Ralph Kettritz, et al.. (2019). 047. CLONAL HEMATOPOIESIS IN PATIENTS WITH ANCA-ASSCOCIATED VASCULITIS. Lara D. Veeken. 58(Supplement_2). 1 indexed citations
10.
Elitok, Saban, Markus Bieringer, Wolfgang Schneider, & Friedrich C. Luft. (2016). Kaliopenic nephropathy revisited. Clinical Kidney Journal. 9(4). 543–546. 6 indexed citations
11.
Elitok, Saban, U. Göbel, Markus Bieringer, et al.. (2010). MYH9 mutation and lupus erythematosus. Clinical Kidney Journal. 3(2). 128–131.
12.
Singer, Eugenia, U. Göbel, Markus Bieringer, et al.. (2008). Cushing’s Disease, Hypertension, and Other Sequels. Hypertension. 52(6). 1001–1005. 3 indexed citations
13.
Fiebeler, Anette, Folke Schmidt, Dominik N. Müller, et al.. (2001). Mineralocorticoid Receptor Affects AP-1 and Nuclear Factor-κB Activation in Angiotensin II–Induced Cardiac Injury. Hypertension. 37(2). 787–793. 172 indexed citations
14.
Dechend, Ralf, Anette Fiebeler, Joon-Keun Park, et al.. (2001). Amelioration of Angiotensin II–Induced Cardiac Injury by a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor. Circulation. 104(5). 576–581. 133 indexed citations
15.
Dechend, Ralf, Anette Fiebeler, Joon-Keun Park, et al.. (2000). Amelioration of Angiotensin Ii-Induced Cardiac Injury by Hmg-Coa Reductase Inhibition. Hypertension. 36. 683–683. 2 indexed citations
16.
Park, Joon-Keun, Dominik N. Müller, Eero Mervaala, et al.. (2000). Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects. Kidney International. 58(4). 1420–1430. 148 indexed citations
17.
Mervaala, Eero, Dominik N. Müller, Joon-Keun Park, et al.. (2000). Cyclosporin A Protects Against Angiotensin II–Induced End-Organ Damage in Double Transgenic Rats Harboring Human Renin and Angiotensinogen Genes. Hypertension. 35(1). 360–366. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eileen Blasi Breakdown of academic impact, for papers by Mathias Burgmaier Breakdown of academic impact, for papers by Joerg Kreuzer Breakdown of academic impact, for papers by Ikuko Nakamura Breakdown of academic impact, for papers by Yasunori Iwashima Breakdown of academic impact, for papers by Masafumi Myoishi Breakdown of academic impact, for papers by Michelle McNabb Breakdown of academic impact, for papers by Lijun Ma Breakdown of academic impact, for papers by Chun Xi Liu Breakdown of academic impact, for papers by Sheng Jiao
Rankless by CCL
2026